Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer's disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Chunyu ^a,b   Zhang, Fan ^b,c   Jiang, Sirui ^b   Siedlak, Sandra L ^b   Shen, Lu ^d   Perry, George ^e   Wang, Xinglong ^b   Tang, Beisha ^d   Zhu, Xiongwei ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHENGDU FIRST PEOPLE S HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; MAPT PROTEIN, HUMAN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; BRAIN CORTEX; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; NEUROFIBRILLARY TANGLE; SIGNAL TRANSDUCTION;

AGED; ALZHEIMER DISEASE; CELL LINE; CEREBRAL CORTEX; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; NEUROFIBRILLARY TANGLES; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84957827761     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20352     Document Type: Article

References (62)

1. Terry, R. D., Masliah, E. & Hansen, L. A. Structural basis of the cognitive alterations in Alzheimer disease. (1994).
2. Markesbery, W. Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiology of aging 18, S13-S19 (1997).
3. Ruitenberg, A., Ott, A., van Swieten, J. C., Hofman, A. & Breteler, M. M. Incidence of dementia: does gender make a difference? Neurobiology of aging 22, 575-580 (2001).
4. Andersen, K. et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53, 1992-1997 (1999).
5. Hojo, Y. et al. Estrogen synthesis in the brain - role in synaptic plasticity and memory. Molecular and cellular endocrinology 290, 31-43 (2008).
6. Wharton, W. et al. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. Journal of Alzheimer's disease 26, 495 (2011).
7. Foster, T. C. Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus 22, 656-669 (2012).
8. Barnes, L. L. et al. Sex differences in the clinical manifestations of Alzheimer disease pathology. Archives of General Psychiatry 62, 685-691 (2005).
9. Daniel, J. M. & Bohacek, J. The critical period hypothesis of estrogen effects on cognition: Insights from basic research. Biochimica et Biophysica Acta (BBA)-General Subjects 1800, 1068-1076 (2010).
10. Henderson, V. W. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. The Journal of steroid biochemistry and molecular biology 142, 99-106, doi: 10.1016/j.jsbmb.2013.05.010 (2014).
11. Xu, H. et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nature medicine 4, 447-451 (1998).
12. C Correia, S. et al. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease? Current aging science 3, 113-126 (2010).
13. Pompili, A., Arnone, B. & Gasbarri, A. Estrogens and memory in physiological and neuropathological conditions. Psychoneuroendocrinology 37, 1379-1396 (2012).
14. Lee, J. H. et al. Targeting estrogen receptors for the treatment of Alzheimer's disease. Molecular neurobiology 49, 39-49 (2014).
15. Goodenough, S., Schleusner, D., Pietrzik, C., Skutella, T. & Behl, C. Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes. Neuroscience 132, 581-589 (2005).
16. Zhang, Q.-G., Wang, R., Khan, M., Mahesh, V. & Brann, D. W. Role of Dickkopf-1, an antagonist of the Wnt/β-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. The Journal of Neuroscience 28, 8430-8441 (2008).
17. Liu, X.-A. et al. Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A. Neurochemical research 33, 1811-1820 (2008).
18. Perlmann, T. & Evans, R. M. Nuclear receptors in Sicily: all in the famiglia. Cell 90, 391-397 (1997).
19. Katzenellenbogen, B. S. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biology of Reproduction 54, 287-293 (1996).
20. Liu, X. et al. Identification of a membrane estrogen receptor in zebrafish with homology to mammalian GPER and its high expression in early germ cells of the testis. Biology of reproduction 80, 1253-1261 (2009).
21. Cui, J., Shen, Y. & Li, R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends in molecular medicine 19, 197-209, doi: 10.1016/j.molmed.2012.12.007 (2013).
22. Perez, S. E., Chen, E.-Y. & Mufson, E. J. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Developmental brain research 145, 117-139 (2003).
23. Paech, K. et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277, 1508-1510 (1997).
24. Yi, P. et al. The effects of estrogen-responsive element-and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ERα and ERβ. Molecular Endocrinology 16, 674-693 (2002).
25. Cowley, S. M. & Parker, M. G. A comparison of transcriptional activation by ERα and ERβ. The Journal of steroid biochemistry and molecular biology 69, 165-175 (1999).
26. McInerney, E. M., Weis, K. E., Sun, J., Mosselman, S. & Katzenellenbogen, B. S. Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ ) Studied with ERβ and ERα Receptor Chimeras 1. Endocrinology 139, 4513-4522 (1998).
27. Tremblay, G. B. et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Molecular endocrinology 11, 353-365 (1997).
28. Mosselman, S., Polman, J. & Dijkema, R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS letters 392, 49-53 (1996).
29. Qu, N., Wang, L., Liu, Z.-C., Tian, Q. & Zhang, Q. Oestrogen receptor α agonist improved long-term ovariectomy-induced spatial cognition deficit in young rats. International Journal of Neuropsychopharmacology 16, 1071-1082 (2013).
30. Zhang, Q.-G. et al. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-α and the critical period hypothesis of estrogen neuroprotection. Proceedings of the National Academy of Sciences 108, E617-E624 (2011).
31. Zhang, Q.-G. et al. Estrogen attenuates ischemic oxidative damage via an estrogen receptor α-mediated inhibition of NADPH oxidase activation. The Journal of neuroscience 29, 13823-13836 (2009).
32. Frye, C. A., Duffy, C. K. & Walf, A. A. Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiology of learning and memory 88, 208-216 (2007).
33. Corbo, R. M., Gambina, G., Ruggeri, M. & Scacchi, R. Association of estrogen receptor α (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Dementia and geriatric cognitive disorders 22, 67-72 (2006).
34. Ji, Y., Urakami, K., Wada-Isoe, K., Adachi, Y. & Nakashima, K. Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia. Dementia and geriatric cognitive disorders 11, 119-122 (2000).
35. Olsen, L. et al. Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women. Psychiatric genetics 16, 85-88 (2006).
36. Yaffe, K., Lui, L.-Y., Grady, D., Stone, K. & Morin, P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biological psychiatry 51, 677-682 (2002).
37. Fugger, H. N., Foster, T. C., Gustafsson, J.-A. & Rissman, E. F. Novel effects of estradiol and estrogen receptor α and β on cognitive function. Brain research 883, 258-264 (2000).
38. Ishunina, T. A. & Swaab, D. F. Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiology of aging 22, 417-426 (2001).
39. Ishunina, T. A. & Swaab, D. F. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging. Experimental neurology 183, 159-172 (2003).
40. Ishunina, T. A., Kamphorst, W. & Swaab, D. F. Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex, aging and Alzheimer's disease. Neurobiology of aging 24, 817-828 (2003).
41. Hestiantoro, A. & Swaab, D. F. Changes in Estrogen Receptor-α and-β in the Infundibular Nucleus of the Human Hypothalamus Are Related to the Occurrence of Alzheimer's Disease Neuropathology. The Journal of Clinical Endocrinology & Metabolism 89, 1912-1925 (2004).
42. Hu, X.-Y. et al. Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients. Acta neuropathologica 106, 213-220 (2003).
43. Zhang, Z. & Simpkins, J. W. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner. Brain research 1345, 176-181, doi: 10.1016/j.brainres.2010.04.074 (2010).
44. Corder, E. H. et al. The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Annals of the New York Academy of Sciences 1019, 24-28 (2004).
45. Salehi, A., Gonzalez Martinez, V. & Swaab, D. F. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiology of aging 19, 505-510 (1998).
46. Xiong, Y. S. et al. Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathway. Aging cell (2015).
47. Luna-Munoz, J. et al. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J. Alzheimers Dis. 8, 29-41 (2005).
48. Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F. & Berry, R. W. Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 1739, 216-223 (2005).
49. Augustinack, J. C., Schneider, A., Mandelkow, E. M. & Hyman, B. T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103, 26-35 (2002).
50. Sortino, M. A. et al. A major role for astrocytes in the neuroprotective effect of estrogen. Drug development research 66, 126-135 (2005).
51. Stirone, C., Duckles, S. P. & Krause, D. N. Multiple forms of estrogen receptor-α in cerebral blood vessels: regulation by estrogen. American Journal of Physiology-Endocrinology and Metabolism 284, E184-E192 (2003).
52. Lu, Y. P. et al. Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease. Experimental neurology 183, 482-488 (2003).
53. Ishunina, T. A., Fischer, D. F. & Swaab, D. F. Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiology of aging 28, 1670-1681 (2007).
54. Ishunina, T. A. & Swaab, D. F. Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain. Neurobiology of aging 33, 286-296. e283 (2012).
55. Li, Z. H. et al. Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy. Medical oncology 30, 591, doi: 10.1007/s12032-013-0591-y (2013).
56. Zhou, J. et al. Predictive value of microtubule-associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane-containing palliative chemotherapy. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 36, 3941-3947, doi: 10.1007/s13277-015-3037-7 (2015).
57. Wang, K. et al. Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 34, 33-38, doi: 10.1007/s13277-012-0507-z (2013).
58. Ikeda, H. et al. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. Breast cancer research: BCR 12, R43, doi: 10.1186/bcr2598 (2010).
59. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group∗ under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-939 (1984).
60. Jicha, G. A., Bowser, R., Kazam, I. G. & Davies, P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128-132 (1997).
61. Greenberg, S. G., Davies, P., Schein, J. D. & Binder, L. I. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267, 564-569 (1992).
62. Smith, M. A. et al. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease. Brain research 717, 99-108 (1996).